Provided by Tiger Trade Technology Pte. Ltd.

Vivos Therapeutics

0.1485
+0.00060.41%
Volume:512.45K
Turnover:74.38K
Market Cap:2.99M
PE:-0.08
High:0.1493
Open:0.1440
Low:0.1431
Close:0.1479
52wk High:3.42
52wk Low:0.1289
Shares:20.12M
Float Shares:19.98M
Volume Ratio:0.14
T/O Rate:2.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8267
EPS(LYR):-2.0700
ROE:-8585.26%
ROA:-56.19%
PB:-0.61
PE(LYR):-0.07

Loading ...

Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2024

Correspondence

Form CORRESP - Correspondence
Jul 30, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Jul 10, 2024

Major Issues Report

Form 8-K - Current report
Jun 25, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report
Apr 24, 2024

Correspondence

Form CORRESP - Correspondence
Apr 22, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 09, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 29, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 01, 2023

Correspondence

Form CORRESP - Correspondence